Literature DB >> 9173930

Identification of candidate proteins binding to prion protein.

F Yehiely1, P Bamborough, M Da Costa, B J Perry, G Thinakaran, F E Cohen, G A Carlson, S B Prusiner.   

Abstract

Prion diseases are disorders of protein conformation that produce neurodegeneration in humans and animals. Studies of transgenic (Tg) mice indicate that a factor designated protein X is involved in the conversion of the normal cellular prion protein (PrPC) into the scrapie isoform (PrPSc); protein X appears to interact with PrPC but not with PrPSc. To search for PrPC binding proteins, we fused PrP with alkaline phosphatase (AP) to produce a soluble, secreted probe. PrP-AP was used to screen a lambdagt11 mouse brain cDNA library, and six clones were isolated. Four cDNAs are novel while two clones are fragments of Nrf2 (NF-E2 related factor 2) transcription factor and Aplp1 (amyloid precursor-like protein 1). The observation that PrP binds to a member of the APP (amyloid precursor protein) gene family is intriguing, in light of possible relevance to Alzheimer's disease. Four of the isolated clones are expressed preferentially in the mouse brain and encode a similar motif.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9173930     DOI: 10.1006/nbdi.1997.0130

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  24 in total

1.  Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.

Authors:  M Horiuchi; B Caughey
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein.

Authors:  L Zulianello; K Kaneko; M Scott; S Erpel; D Han; F E Cohen; S B Prusiner
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Identification of multiple quantitative trait loci linked to prion disease incubation period in mice.

Authors:  S E Lloyd; O N Onwuazor; J A Beck; G Mallinson; M Farrall; P Targonski; J Collinge; E M Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

Review 4.  Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease.

Authors:  Haakon B Nygaard; Stephen M Strittmatter
Journal:  Arch Neurol       Date:  2009-11

5.  Prion and doppel proteins bind to granule cells of the cerebellum.

Authors:  Giuseppe Legname; Peter Nelken; Zhengyu Guan; Zoltan F Kanyo; Stephen J DeArmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-21       Impact factor: 11.205

6.  Cellular prion protein transduces neuroprotective signals.

Authors:  Luciana B Chiarini; Adriana R O Freitas; Silvio M Zanata; Ricardo R Brentani; Vilma R Martins; Rafael Linden
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

7.  Detection of new quantitative trait Loci for susceptibility to transmissible spongiform encephalopathies in mice.

Authors:  Carole R Moreno; Frédéric Lantier; Isabelle Lantier; Pierre Sarradin; Jean-Michel Elsen
Journal:  Genetics       Date:  2003-12       Impact factor: 4.562

8.  Complexity of CNC transcription factors as revealed by gene targeting of the Nrf3 locus.

Authors:  Anna Derjuga; Tania S Gourley; Teresa M Holm; Henry H Q Heng; Ramesh A Shivdasani; Rafi Ahmed; Nancy C Andrews; Volker Blank
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

Review 9.  Interactions of prion protein with intracellular proteins: so many partners and no consequences?

Authors:  Krzysztof Nieznanski
Journal:  Cell Mol Neurobiol       Date:  2009-12-30       Impact factor: 5.046

10.  Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.

Authors:  Juha Laurén; David A Gimbel; Haakon B Nygaard; John W Gilbert; Stephen M Strittmatter
Journal:  Nature       Date:  2009-02-26       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.